Virasoft is participating in a joint-project to develop machine learning-based diagnostic tool against Breast Cancer

ISTANBUL, August 26, 2022 – Breast cancer is an urgent worldwide issue in fact the burden this global problem is increasing. Early diagnosis is the most important parameter for breast cancer as it is for the other progressive diseases. Moreover, limited access to healthcare and adequate resources requires multidisciplinary approach to manage breast cancer cases.

At Virasoft, we launched a project to build a machine learning model for breast cancer diagnosis featuring oncological treatment methodologies. The collaborative project among 4 countries including Belgium, Slovenia, Spain and Turkey, aims to aid physicians in decision making process for patient care with AI-powered algorithms on reliable outcomes. ITEA project called HeKDisco : Healthcare Knowledge Discovery promises reduced clinical errors, precise early diagnosis, more accessible individual patient care and therapeutic outcome prediction.

###

About Virasoft

Virasoft is a technology startup, focused on AI-powered decision support algorithms, digital pathology workflow solutions, telepathology systems and educational tools for pathologists and pathology laboratories. Virasoft is headquartered in New York with offices in Istanbul, Turkey. Broad-based spectrum of services enables accessing and curating data for the development of the deep learning algorithms.